Posts by Mary E. Sabatini, MD, PhD
-
The Müllerian Inhibiting Substance: Changing the Fertility Landscape for Young Women with Cancer
New oncofertility research at Mass General offers a promising new paradigm for a reversible contraceptive that may help protect the ovaries during chemotherapy.
Biography
Mary Sabatini, MD, PhD, is the medical director of the Oncofertility Clinic and the medical director of the Third-Party Reproduction Program in the Reproductive Endocrinology and Infertility Division of the Department of Obstetrics and Gynecology at Massachusetts General Hospital. She is an assistant professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School.
Her primary research interests include exploring novel approaches to fertility preservation in those diagnosed with cancer and understanding clinical outcomes for women with hereditary cancer syndromes.
